Hims & Hers Health Q2 2026 Revenue Up 38% to $753 Million; EPS Loss $0.37
Hims & Hers Health reported second-quarter 2026 revenue of $753 million, up 38% year over year, and a diluted loss per share of $0.37, reversing from a profit in the same quarter of the prior year. The results, announced in the company's quarterly earnings release, reflect strong top-line growth amid a shift to a bottom-line loss, marking a notable change from the prior-year period's profitability.
Hims & Hers Health reported its second-quarter 2026 financial results. Revenue for the quarter was $753 million, up 38% year over year, while diluted loss per share was $0.37, turning from a profit in the same period a year ago.
Why this event matters
The event has a measured impact on 1 industry. The strongest current signal is mixed for Telemedicine, with intensity 40/100 and 60% confidence over a short term horizon.
Impact figures are analytical estimates that combine direction, intensity, confidence and event importance. They are not investment advice.